Table 3.
Electrode Materials | Target | Linear Range | Detection Limit | Ref. |
---|---|---|---|---|
Graphene Oxide/probe DNA | HIV-1 gene (cDNA) | 1 pM–1 μM | 0.11 pM | [70] |
Reduced graphene nanowalls | dsDNA | 0.1 fM–10 mM | 9.4 zM | [71] |
Graphene oxide modified iron Oxide/chitosan/probe DNA |
Escherichia coli Ο157:¨Η7 gene (cDNA) | 10 fM–1 μM | 10 fM | [72] |
Screen-printed carbon/reduced graphene oxide/Carboxy-methyl-cellulose/probe DNA | p53 tumor suppressor gene (cDNA) |
10 nM–0.1 μM | 2.9 nM | [73] |
Nitrogen-doped graphene/Au nanoparticles/probe DNA | multidrug resistance gene | 10 fM–100 nM | 3.12 fM | [77] |
Fe3O4 Nanoparticles/reduced graphene oxide | HIV-1 gene (cDNA) |
10 aM–100 pM | - | [78] |
Glassy carbon/reduced graphene oxide/polypyrrole–3–carboxylic acid | Breast cancer 1 gene | 1 pM–0.1 μM | 0.3 pM | [79] |
Gold nanorods/graphene/ hairpin-shaped DNA aptamer | Carcinoembryonic antigen | 5 pg·mL−1–50 ng·mL−1 | 1.5 pg·mL−1 | [75] |
Graphene quantum dot-ionic liquid-nafion/hairpin aptamer | Carcinoembryonic antigen | 0.5 fg·mL−1–0.5 ng mL−1 | 0.34 fg·mL−1 | [80] |
Graphene/glassy carbon/aptamer | Carcinoembryonic antigen | 80 ag·mL−1–950 fg·mL−1 | 80 ag·mL−1 | [81] |
Glassy carbon/graphene oxide methylene blue/Antibody | White spot syndrome virus | 1.36 × 10−3–107 copies·µL−1 | 103 copies·µL−1 | [76] |
Graphene-wrapped copper oxide/cysteine | E. coli O157:H7 | 10 CFU·mL−1–108 CFU·mL−1 | 3.8 CFU·mL−1 | [82] |
Gold/reduced graphene oxide/polyethylenimine | E. coli | 10 CFU·mL−1–104 CFU·mL−1 | 10 CFU·mL−1 | [83] |